NCT03493503View on ClinicalTrials.gov

Status Asthmaticus on the PICU; Intravenous Salbutamol

PHASE4CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

April 5, 2017

Primary Completion Date

May 21, 2019

Study Completion Date

May 21, 2019

Conditions
Childhood Asthma With Status Asthmaticus
Interventions
DRUG

Salbutamol

Intravenous Salbutamol loading dose

DRUG

Sodium Chloride 0.9%

10 ml of Sodium Chloride 0.9% in 10 minutes intravenous

Trial Locations (1)

3000WB

Erasmus MC, Rotterdam

Sponsors
All Listed Sponsors
lead

Erasmus Medical Center

OTHER

NCT03493503 - Status Asthmaticus on the PICU; Intravenous Salbutamol | Biotech Hunter | Biotech Hunter